IJERPH | Free Full-Text | Allergic Diseases: A Comprehensive Review on Risk Factors, Immunological Mechanisms, Link with COVID-19, Potential Treatments, and Role of Allergen Bioinformatics
RCSB PDB - 3OB4: MBP-fusion protein of the major peanut allergen Ara h 2
Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform | Scientific Reports
Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen | PNAS
Ara h 2-and Ara h 6-Specific IgE Concentrations of Sera of... | Download Table
Peanut Allergy Diagnosis: As Simple as Ara h 1, 2, and 3 | Consultant360
Vaccination against Allergy: A Paradigm Shift?: Trends in Molecular Medicine
PDF) Ara h 2.02 as a potential candidate protein for a better diagnosis
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity - ScienceDirect
Peanut Allergy, Allergen Composition, and Methods of Reducing Allergenicity: A Review
Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6 - ScienceDirect
Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform | Scientific Reports
Molecular allergology and its impact in specific allergy diagnosis and therapy - Barber - 2021 - Allergy - Wiley Online Library
Severity of Peanut Allergy and the Unmet Gaps in Care: A Call to Action
Nutrients | Free Full-Text | Release of Major Peanut Allergens from Their Matrix under Various pH and Simulated Saliva Conditions—Ara h2 and Ara h6 Are Readily Bio-Accessible
Cross-Reactivity of Peanut Allergens | SpringerLink
Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6 - ScienceDirect
Frontiers | IgE-Mediated Peanut Allergy: Current and Novel Predictive Biomarkers for Clinical Phenotypes Using Multi-Omics Approaches
Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform | Scientific Reports
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity
Frontiers | From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack
Cross-Reactivity of Peanut Allergens | SpringerLink
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity - ScienceDirect
